Autotaxin and Lysophosphatidic Acid Signalling: the Pleiotropic Regulatory Network in Cancer
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
Grantová podpora
NU23-01-00323
Ministerstvo Školství, Mládeže a Tělovýchovy
PubMed
38583176
DOI
10.14712/fb2023069050149
PII: fb_2023069050149
Knihovny.cz E-zdroje
- Klíčová slova
- ENPP2, LPA, autotaxin, cancer, lysophosphatidic acid, signal transduction,
- MeSH
- fosfodiesterasy * genetika chemie metabolismus MeSH
- lidé MeSH
- lysofosfolipidy metabolismus MeSH
- nádory * MeSH
- signální transdukce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- fosfodiesterasy * MeSH
- lysofosfolipidy MeSH
- lysophosphatidic acid MeSH Prohlížeč
Autotaxin, also known as ecto-nucleotide pyrophosphatase/phosphodiesterase family member 2, is a secreted glycoprotein that plays multiple roles in human physiology and cancer pathology. This protein, by converting lysophosphatidylcholine into lysophosphatidic acid, initiates a complex signalling cascade with significant biological implications. The article outlines the autotaxin gene and protein structure, expression regulation and physiological functions, but focuses mainly on the role of autotaxin in cancer development and progression. Autotaxin and lysophosphatidic acid signalling influence several aspects of cancer, including cell proliferation, migration, metastasis, therapy resistance, and interactions with the immune system. The potential of autotaxin as a diagnostic biomarker and promising drug target is also examined.
Citace poskytuje Crossref.org